Anxiety Disorders Completed Phase 4 Trials for Sertraline (DB01104)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00872131Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder